T13	Effect 112 235	weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
T16	Drug 25 46	5-aminosalicylic acid
T18	Drug 5 9	SASP
T19	Subject 99 101	he
T20	Treat-Disorder 60 74	skin eruptions
T21	Treatment 5 54	SASP was changed to 5-aminosalicylic acid (5-ASA)
T22	Treatment 5 54	SASP was changed to 5-aminosalicylic acid (5-ASA)
T23	Drug 5 9	SASP
T24	Drug 25 46	5-aminosalicylic acid
